Lincoln Financial hit with hefty arbitration award over selling away

Finra panel ruled that the B-D was 'negligent in not preventing' the outside business activities of a former broker
OCT 14, 2010
Lincoln Financial Advisors Corp. has been ordered by a Finra arbitration panel to pay $4.43 million in damages and interest to roughly two dozen former clients who alleged that an ex-managing director at the firm was involved in a “selling away” scheme. A three-person Financial Industry Regulatory Authority Inc. panel ruled Sept. 27 that Lincoln Financial Advisors was “negligent in not preventing” the actions of Scott Gordon, who, while registered with Lincoln, was raising money from investors for an outside business. Selling away is industry shorthand for brokers' offering a product to clients without the broker-dealer's knowledge or approval. Some broker-dealers allow their reps to have outside businesses, as long as the activity is disclosed. According to the Finra arbitrator's decision, Mr. Gordon became chief executive of a software development company, Healthright Inc., in 2005, while he was affiliated with Lincoln. He identified himself as working for Healthright in Lincoln e-mails, the panel said, and eventually began using a footer on his Lincoln e-mail account that referred to him as chairman and CEO of Healthright, and included the company's address and phone number, the ruling said. Lincoln, however, failed to keep close track of Mr. Gordon's outside work, the panel ruled. Mr. Gordon told Lincoln of his job at Healthright when he submitted an outside-business-activity disclosure form to the company, but Lincoln did not approve or deny the request, according to the panel's decision. The claimants in the matter are Healthright and Grant Gifford, an investor in the company. In May 2006, Mr. Gordon was no longer the CEO of Healthright. A month later, Mr. Gifford attended his first board-of-directors meeting for the company and “discovered that misstatements and omissions had been made by Mr. Gordon, and in addition, there had been certain irregularities in the management and operations of Healthright,” the panel said in its decision. The Finra arbitrators found that Lincoln's “negligence caused the loss of claimants' investments in Healthright.” The panel ordered Lincoln to pay Mr. Gifford $300,000 plus interest of $66,000 and Healthright $3.33 million plus interest of $733,000. About two dozen investors had invested in Healthright through Mr. Gordon. The dispute involved investments in common stock, limited partnerships and private equities issued by Healthright. Lincoln fired Mr. Gordon, who joined the firm in 1997 and rose to managing director. He was fired in September 2006. Finra barred him from the securities industry in 2008. Mr. Gordon could not be reached to comment. “It's a matter of corporate policy that we don't comment” on arbitration decisions, said Eric Samansky, a spokesman for Lincoln. Lincoln Financial Advisors had $318 million in revenue last year, according to its filings with the Securities and Exchange Commission.

Latest News

Retirement plan defaults leave key participant decisions unresolved
Retirement plan defaults leave key participant decisions unresolved

New Allspring research finds 401(k) participants want guidance on income and rollovers, not just portfolio automation.

Global equity release market set to triple, with US leading growth
Global equity release market set to triple, with US leading growth

Aging homeowners hold record housing wealth - but most advisors still aren't bringing it into retirement plans

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor